What Is an AdCom? One of the Most Important FDA Events People Still Underestimate
AdCom is short for advisory committee meeting. In biotech and pharmaceutical news, it refers to a public FDA meeting where outside experts review a drug application and discuss the evidence before the agency makes an approval decision. The committee does not make the final call, but its discussion and vote can shape market expectations quickly.